Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating a polysaccharide superparamagnetic iron oxide contrast agent for cardiovascular MRI in diabetic …
-
CLINICAL_TRIALS withdrawal · 2023-09-28Clinical Trial Update: Polypill Effects on Sub Clinical Atherosclerosis (PESCA) Trial [Phase 3]
Phase 3 trial PESCA investigating polypill effects on subclinical atherosclerosis was withdrawn.
-
FDA approval · 2023-09-12FDA Approved: JARDIANCE — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JARDIANCE (empagliflozin) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Evaluation of a Letter Intervention Promoting a Plant-based Diet [NA]
Geisinger Clinic completed a trial evaluating a letter intervention promoting a plant-based diet and has posted results, targeting cardiovas…
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study [Phase 2]
Phase 2 dose-finding trial of olpasiran evaluating lipoprotein(a) reduction and cardiovascular event outcomes, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Targeting Physical Activity to Improve Cardiovascular Health in Type 2 Diabetes [NA]
A completed clinical trial evaluating the impact of targeted physical activity to improve cardiovascular health in people with type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Vascular Risk After Kidney Transplantation
Clinical trial update reporting vascular risk after kidney transplantation with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Contribution of Dolutegravir to Obesity and Cardiovascular Disease [Phase 4]
A Phase 4 clinical trial evaluating the contribution of dolutegravir to obesity and cardiovascular disease in HIV-1 infection has completed.
-
FDA approval · 2023-07-25FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Quallent)
FDA approved a supplemental application for atorvastatin calcium from Quallent, indicating a new approval-related action for this generic st…
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk [NA]
A completed clinical trial evaluated a smartphone-based application to manage cardiovascular disease risk after myocardial infarction in pat…
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Effects of Eplerenone on Cardiovascular Disease in HIV (MIRACLE HIV Study) [NA]
A completed clinical trial evaluating the effects of eplerenone on cardiovascular disease in people with HIV.
-
FDA approval · 2023-06-02FDA Approved: PITAVASTATIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pitavastatin from Aurobindo Pharma Limited (ANDA206015).
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: PREVENT Tool Study: Late Effects Clinic [NA]
A completed clinical trial update for the PREVENT Tool Study in a late effects clinic, focusing on cardiovascular disease and childhood obes…
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk [Phase 2]
Phase 2 trial evaluating IL-1β inhibition to reduce inflammation and cardiovascular risk in people with HIV and cardiovascular disease; resu…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM [Phase 3]
Phase 3 trial evaluating REX-001 for ischemic ulcers in patients with Critical Limb Ischemia (CLI) and diabetes was terminated.
-
CLINICAL_TRIALS withdrawal · 2023-03-10Clinical Trial Update: Early Mobilization in Older Adults With Acute Cardiovascular Disease [Phase 3]
A phase 3 clinical trial investigating early mobilization in older adults with acute cardiovascular disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: Congenital Heart Disease Physical Activity Lifestyle Study [NA]
A completed clinical trial on physical activity lifestyle in congenital heart disease, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer [Phase 2]
Phase 2 trial evaluating prevention of cardiovascular diseases in women with breast cancer undergoing complex treatment; completed.
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries [Phase 3]
Amgen's Fourier open-label extension study in adults with clinically evident cardiovascular disease and dyslipidemia was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) [Phase 2]
Phase 2 trial of ISIS 678354 (AKCEA-APOCIII-LRx) in participants with hypertriglyceridemia and established cardiovascular disease completed …
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET [NA]
A completed clinical trial update from the SPREAD-NET study. No phase information available.
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients [Phase 4]
A Phase 4 trial evaluating a fixed-dose intervention to enhance survival in patients with serious mental illness, including schizophrenia an…
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol [Phase 1, Phase 2]
Phase 1/2 safety and pharmacokinetic study of RVX000222 in healthy subjects and individuals with low HDL cholesterol completed.
-
FDA approval · 2022-11-03FDA Approved: ATORVASTATIN CALCIUM — Original Application (Lepu Pharmaceutical Technology Co., Ltd.)
FDA approves the original application for atorvastatin calcium (generic) from Lepu Pharmaceutical Technology Co., Ltd. The approval adds a g…
-
CLINICAL_TRIALS withdrawal · 2022-09-21Clinical Trial Update: Single Pill to Avert Cardiovascular Events [Phase 3]
Phase 3 cardiovascular trial was withdrawn.